Handling of allergen immunotherapy in the COVID-19 pandemic: an ARIA-EAACI statement

Ludger Klimek; Marek Jutel; Cezmi Akdis; Jean Bousquet; Mübeccel Akdis; Claus Bachert; Ioana Agache; Ignacio Ansotegui; Anna Bedbrook; Sinthia Bosnic-Anticevich; G. Walter Canonica; Tomas Chivato; Alvaro A. Cruz; Wienczyslawa Czarlewski; Stefano Del Giacco; Hui Du; Joao A. Fonseca; Yadong Gao; Tari Haahtela; Karin Hoffmann-Sommergruber; Juan-Carlos Ivancevich; Nikolai Khaltaev; Edward F. Knol; Piotr Kuna; Desiree Larenas-Linnemann; Erik Melen; Joaquim Mullol; Robert Naclerio; Ken Ohta; Yoshitaka Okamoto; Liam O’Mahony; Gabrielle L. Onorato; Nikos G. Papadopoulos; Ruby Pawankar; Oliver Pfaar; Boleslaw Samolinski; Jurgen Schwarze; Sanna Toppila-Salmi; Mohamed H. Shamji; Maria Teresa Ventura; Arunas Valiulis; Arzu Yorgancioglu; Paolo Matricardi; Torsten Zuberbier; the ARIA-MASK Study Group

doi:10.1111/all.14336

Handling of allergen immunotherapy in the COVID-19 pandemic: an ARIA-EAACI statement

Ludger Klimek, Marek Jutel, Cezmi Akdis, Jean Bousquet, Mübeccel Akdis, Claus Bachert, Ioana Agache, Ignacio Ansotegui, Anna Bedbrook, Sinthia Bosnic-Anticevich, G. Walter Canonica, Tomas Chivato, Alvaro A. Cruz, Wienczyslawa Czarlewski, Stefano Del Giacco, Hui Du, Joao A. Fonseca, Yadong Gao, Tari Haahtela, Karin Hoffmann-SommergruberJuan-Carlos Ivancevich, Nikolai Khaltaev, Edward F. Knol, Piotr Kuna, Desiree Larenas-Linnemann, Erik Melen, Joaquim Mullol, Robert Naclerio, Ken Ohta, Yoshitaka Okamoto, Liam O’Mahony, Gabrielle L. Onorato, Nikos G. Papadopoulos, Ruby Pawankar, Oliver Pfaar, Boleslaw Samolinski, Jurgen Schwarze, Sanna Toppila-Salmi, Mohamed H. Shamji, Maria Teresa Ventura, Arunas Valiulis, Arzu Yorgancioglu, Paolo Matricardi, Torsten Zuberbier, the ARIA-MASK Study Group

Research output: Contribution to journal › Article › peer-review

96 Citations (Scopus)

Abstract

The current COVID-19 pandemic influences many aspects of personal and social interaction, including patient contacts with health care providers and the manner in which allergy care is provided and maintained. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on inducing an appropriate immune response in the allergic patient. This manuscript outlines the EAACI recommendations regarding AIT during the COVID-19 pandemic and aims at supporting allergists and all physicians performing AIT in their current daily practice with clear recommendations on how to perform treatment during the pandemic and in SARS-CoV-2 infected patients.

Original language	English
Pages (from-to)	1546-1554
Number of pages	9
Journal	Allergy: European Journal of Allergy and Clinical Immunology
Volume	75
Issue number	7
DOIs	https://doi.org/10.1111/all.14336
Publication status	Published - Jul 2020
Externally published	Yes

Keywords

allergy treatment
immunotherapy clinical
immunotherapy vaccines and mechanisms

Access to Document

10.1111/all.14336

Cite this

Klimek, L., Jutel, M., Akdis, C., Bousquet, J., Akdis, M., Bachert, C., Agache, I., Ansotegui, I., Bedbrook, A., Bosnic-Anticevich, S., Canonica, G. W., Chivato, T., Cruz, A. A., Czarlewski, W., Del Giacco, S., Du, H., Fonseca, J. A., Gao, Y., Haahtela, T., ... the ARIA-MASK Study Group (2020). Handling of allergen immunotherapy in the COVID-19 pandemic: an ARIA-EAACI statement. Allergy: European Journal of Allergy and Clinical Immunology, 75(7), 1546-1554. https://doi.org/10.1111/all.14336

@article{269e774a7a8d45e89654235d5d77445a,

title = "Handling of allergen immunotherapy in the COVID-19 pandemic: an ARIA-EAACI statement",

abstract = "The current COVID-19 pandemic influences many aspects of personal and social interaction, including patient contacts with health care providers and the manner in which allergy care is provided and maintained. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on inducing an appropriate immune response in the allergic patient. This manuscript outlines the EAACI recommendations regarding AIT during the COVID-19 pandemic and aims at supporting allergists and all physicians performing AIT in their current daily practice with clear recommendations on how to perform treatment during the pandemic and in SARS-CoV-2 infected patients.",

keywords = "allergy treatment, immunotherapy clinical, immunotherapy vaccines and mechanisms",

author = "Ludger Klimek and Marek Jutel and Cezmi Akdis and Jean Bousquet and M{\"u}beccel Akdis and Claus Bachert and Ioana Agache and Ignacio Ansotegui and Anna Bedbrook and Sinthia Bosnic-Anticevich and Canonica, {G. Walter} and Tomas Chivato and Cruz, {Alvaro A.} and Wienczyslawa Czarlewski and {Del Giacco}, Stefano and Hui Du and Fonseca, {Joao A.} and Yadong Gao and Tari Haahtela and Karin Hoffmann-Sommergruber and Juan-Carlos Ivancevich and Nikolai Khaltaev and Knol, {Edward F.} and Piotr Kuna and Desiree Larenas-Linnemann and Erik Melen and Joaquim Mullol and Robert Naclerio and Ken Ohta and Yoshitaka Okamoto and Liam O{\textquoteright}Mahony and Onorato, {Gabrielle L.} and Papadopoulos, {Nikos G.} and Ruby Pawankar and Oliver Pfaar and Boleslaw Samolinski and Jurgen Schwarze and Sanna Toppila-Salmi and Shamji, {Mohamed H.} and Ventura, {Maria Teresa} and Arunas Valiulis and Arzu Yorgancioglu and Paolo Matricardi and Torsten Zuberbier and {the ARIA-MASK Study Group}",

year = "2020",

month = jul,

doi = "10.1111/all.14336",

language = "English",

volume = "75",

pages = "1546--1554",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell, Wiley",

number = "7",

}

Klimek, L, Jutel, M, Akdis, C, Bousquet, J, Akdis, M, Bachert, C, Agache, I, Ansotegui, I, Bedbrook, A, Bosnic-Anticevich, S, Canonica, GW, Chivato, T, Cruz, AA, Czarlewski, W, Del Giacco, S, Du, H, Fonseca, JA, Gao, Y, Haahtela, T, Hoffmann-Sommergruber, K, Ivancevich, J-C, Khaltaev, N, Knol, EF, Kuna, P, Larenas-Linnemann, D, Melen, E, Mullol, J, Naclerio, R, Ohta, K, Okamoto, Y, O’Mahony, L, Onorato, GL, Papadopoulos, NG, Pawankar, R, Pfaar, O, Samolinski, B, Schwarze, J, Toppila-Salmi, S, Shamji, MH, Ventura, MT, Valiulis, A, Yorgancioglu, A, Matricardi, P, Zuberbier, T & the ARIA-MASK Study Group 2020, 'Handling of allergen immunotherapy in the COVID-19 pandemic: an ARIA-EAACI statement', Allergy: European Journal of Allergy and Clinical Immunology, vol. 75, no. 7, pp. 1546-1554. https://doi.org/10.1111/all.14336

TY - JOUR

T1 - Handling of allergen immunotherapy in the COVID-19 pandemic

T2 - an ARIA-EAACI statement

AU - Klimek, Ludger

AU - Jutel, Marek

AU - Akdis, Cezmi

AU - Bousquet, Jean

AU - Akdis, Mübeccel

AU - Bachert, Claus

AU - Agache, Ioana

AU - Ansotegui, Ignacio

AU - Bedbrook, Anna

AU - Bosnic-Anticevich, Sinthia

AU - Canonica, G. Walter

AU - Chivato, Tomas

AU - Cruz, Alvaro A.

AU - Czarlewski, Wienczyslawa

AU - Del Giacco, Stefano

AU - Du, Hui

AU - Fonseca, Joao A.

AU - Gao, Yadong

AU - Haahtela, Tari

AU - Hoffmann-Sommergruber, Karin

AU - Ivancevich, Juan-Carlos

AU - Khaltaev, Nikolai

AU - Knol, Edward F.

AU - Kuna, Piotr

AU - Larenas-Linnemann, Desiree

AU - Melen, Erik

AU - Mullol, Joaquim

AU - Naclerio, Robert

AU - Ohta, Ken

AU - Okamoto, Yoshitaka

AU - O’Mahony, Liam

AU - Onorato, Gabrielle L.

AU - Papadopoulos, Nikos G.

AU - Pawankar, Ruby

AU - Pfaar, Oliver

AU - Samolinski, Boleslaw

AU - Schwarze, Jurgen

AU - Toppila-Salmi, Sanna

AU - Shamji, Mohamed H.

AU - Ventura, Maria Teresa

AU - Valiulis, Arunas

AU - Yorgancioglu, Arzu

AU - Matricardi, Paolo

AU - Zuberbier, Torsten

AU - the ARIA-MASK Study Group

PY - 2020/7

Y1 - 2020/7

N2 - The current COVID-19 pandemic influences many aspects of personal and social interaction, including patient contacts with health care providers and the manner in which allergy care is provided and maintained. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on inducing an appropriate immune response in the allergic patient. This manuscript outlines the EAACI recommendations regarding AIT during the COVID-19 pandemic and aims at supporting allergists and all physicians performing AIT in their current daily practice with clear recommendations on how to perform treatment during the pandemic and in SARS-CoV-2 infected patients.

AB - The current COVID-19 pandemic influences many aspects of personal and social interaction, including patient contacts with health care providers and the manner in which allergy care is provided and maintained. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on inducing an appropriate immune response in the allergic patient. This manuscript outlines the EAACI recommendations regarding AIT during the COVID-19 pandemic and aims at supporting allergists and all physicians performing AIT in their current daily practice with clear recommendations on how to perform treatment during the pandemic and in SARS-CoV-2 infected patients.

KW - allergy treatment

KW - immunotherapy clinical

KW - immunotherapy vaccines and mechanisms

UR - http://www.scopus.com/inward/record.url?scp=85084617822&partnerID=8YFLogxK

U2 - 10.1111/all.14336

DO - 10.1111/all.14336

M3 - Article

C2 - 32329930

SN - 0105-4538

VL - 75

SP - 1546

EP - 1554

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 7

ER -

Handling of allergen immunotherapy in the COVID-19 pandemic: an ARIA-EAACI statement

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this